论文部分内容阅读
为了探讨纤维结合蛋白(FN)和纤维酶原(PG)与脑血管病的关系,选择了符合1986年全国脑血管病会议诊断标准,并除外肝、肾、心脏疾患。全部病例均经头部CT或MR证实的脑血管病人共76例,其中脑血栓形成40例,男24例,女16例,年龄32～80岁,平均60.3岁,初次发病16例,脑血栓恢复期(病后4周)24例;脑出血36例,男19例,女17例,年龄38～83岁,平均60岁。正常对照60例,年龄25～45岁。采用散射比浊法测定血浆FN和PG。血浆FN测定结果如下:脑血栓形成早期0.33±0.07g/L,恢复期0.29±0.01g/L,脑出血0.30±0.06g/L,正
In order to investigate the relationship between fibronectin (FN) and fibrinogen (PG) and cerebrovascular disease, we selected the diagnostic criteria of the National Conference on Cerebrovascular Disease in 1986, with the exception of liver, kidney and heart disease. All cases were confirmed by head CT or MR of cerebrovascular patients were 76 cases, including cerebral thrombosis in 40 cases, 24 males and 16 females, aged 32 to 80 years, mean 60.3 years, the initial incidence of 16 cases of cerebral thrombosis The recovery period (4 weeks after illness) 24 cases; cerebral hemorrhage in 36 cases, 19 males and 17 females, aged 38 to 83 years, mean 60 years. 60 cases of normal control, aged 25 to 45 years old. Plasma FN and PG were measured by nephelometry. The results of plasma FN were as follows: 0.33 ± 0.07g / L at early stage of cerebral thrombosis, 0.29 ± 0.01g / L at recovery, 0.30 ± 0.06g / L at cerebral hemorrhage,